Chronic myeloid leukemia (CML) is characterized by the Philadelphia (Ph) chromosome, an acquired clonal abnormality resulting from the translocation of chromosomes and the generation of BCR-ABL fusion oncogenes. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.